SPONSOR

University of Washington

Total Trials

Recruiting

Phases

Phase 1, Phase 2, Phase 1, Phase 2, Phase 3

Conditions studied: Prostatic Neoplasms Metastatic Lung Non-Small Cell Carcinoma Recurrent Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8 Depression Lower Limb Amputation Below Knee (Injury)Diurnal Residual Limb Fluid Volume Fluctuation Spinal Cord Injuries Behavior, Child Malnutrition in Children

University of Washington is a clinical research sponsor with 34 registered studies on ClinicalTrials.gov, of which 34 are actively recruiting participants. Research covers conditions including Prostatic Neoplasms, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.

The trial portfolio spans Phase 1, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Washington

How many clinical trials has University of Washington sponsored?

ClinicalMetric currently tracks 34 clinical trials sponsored by University of Washington, of which 34 are actively recruiting participants. These trials cover conditions including Prostatic Neoplasms, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Washington research focus on?

University of Washington clinical trials span Prostatic Neoplasms, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Depression, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Washington clinical trial?

To participate in a University of Washington trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Washington trials with current recruitment status updated daily.

University of Washington

Frequently Asked Questions — University of Washington

Clinical Trials by University of Washington

Prostate Active Surveillance Study

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Lay-Delivered Behavioral Activation in Senior Centers

An Automatically Adjusting Prosthetic Socket for People With Transtibial Amputation

Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury

BASIS-T Efficacy Trial

Implementation of Problem-Solving Treatment in Community Health Centers (PST-Aid)

A Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients

SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection

Scale-up of an Evidence-based Adolescent Transition Package to Support Transitional Care Among Youth Living With HIV

Autologous Mitochondrial Transplant for Cerebral Ischemia

Prevention of Developmental Delay and Xylitol (PDDaX) Study

Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

CIH Stepped Care for Co-occurring Chronic Pain and PTSD

Preliminary Efficacy of an mHealth Intervention in West Africa

Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma

Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault

The Airports, Air Quality, and Asthma (AAA) Study

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

CORE (Cognitive Optimization Through Rehabilitation and Education) Study

Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic

Optimizing Infection Prophylaxis Prior to Shoulder Surgery

InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Limited Versus Extended Trophic Feeding (LET-FEED) Trial

Iterative Redesign of a Multifaceted Implementation Strategy for a School-based Behavioral Skills Intervention (RUBI)

Copper Supplementation in Cirrhosis

A Pilot Study of The CKM JumpStart Tool

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms